Researchers publishing in ACS' Journal of Medicinal Chemistry have developed a new cancer therapy that is kept "locked" unless it finds itself within a tumor cell. In mice, the treatment significantly reduced tumor size without accumulating in the liver, which suggests adverse exposures could be reduced and treatment safety improved.